Scottish university reveals multimillion-pound Parkinson’s research partnership

News

Author: Roisin McCormackPublished: 10 July 2019

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Doctor analysing patient brain scan results

The University of Dundee, UK, has announced a collaboration with South Korean pharmaceutical company Bukwang to develop a new treatment for Parkinson’s.

Collaborating with researchers at the University of Oxford, UK, the university’s drug discovery unit (DDU) has found molecules that may reduce levels of a protein closely connected to the development of the condition.

The new partnership will build on this existing relationship between the universities – and facilitate a further three-year Parkinson’s research programme which will move the molecules towards clinical development.

Professor Paul Wyatt, head of the DDU, said: “Drug discovery for neurological disorders is especially challenging and an area where academia and industry need to be working together.

“This project brings together the clinical and translational research expertise in Oxford with Dundee’s professional drug-discovery capabilities, allowing us to move one stage further towards a treatment.”

To read more on this topic click here.


Read more:

Parkinson’s may originate in the gut, says new study

Acupuncture may alleviate Parkinson’s symptoms

Go Back

Share this story

Comments


Related articles


cloudUPDRS-app-lead

Resources & Tools

New Parkinson’s app tracks symptoms

A new app has been developed to track Parkinson’s symptoms

READ MORE
Carol Walton lead

Interviews

“We want the world to walk with us,” says Parkinson’s Unity Walk leader

2016 Parkinson’s Unity Walk hopes to raise more than US$1.7m

READ MORE
needle-lead

Advances

The huge potential of nanotechnology on new Parkinson’s treatments

Can tiny mesh electronics revolutionise Parkinson’s treatments?

READ MORE